A nurse is teaching about glucose monitoring. How often should a pregnant client with pregestational diabetes mellitus check their glucose in a day?

Nonsteroidal anti-inflammatory drugs (NSAIDs) inhibit the enzyme cyclooxygenase, which is responsible for the synthesis of prostaglandins. Primary dysmenorrhea is caused by an excess of prostaglandin F2-alpha, which triggers intense uterine contractions and ischemia. Reducing these levels effectively alleviates menstrual cramping and associated systemic symptoms.

A. Antidepressants: While SSRIs are used for the emotional symptoms of premenstrual dysphoric disorder, they are not the first-line treatment for the physical pain of dysmenorrhea. They do not inhibit the uterine prostaglandins that cause the primary cramping. They address neurological rather than myometrial targets.

B. Insulin: Insulin is used to manage diabetes mellitus and has no clinical role in the treatment of menstrual pain. It does not affect uterine contractility or prostaglandin levels. Administering it to a non-diabetic client would cause life-threatening hypoglycemia.

C. Antibiotics: These agents treat infections like pelvic inflammatory disease, which can cause secondary dysmenorrhea. However, they are not used for the symptomatic relief of standard menstrual cramps. Antibiotics do not have analgesic or anti-inflammatory properties for non-infectious pelvic pain.

D. NSAIDS: Drugs like ibuprofen and naproxen are the gold standard for treating dysmenorrhea because they target the biochemical cause of the pain. By lowering prostaglandin concentrations in the menstrual fluid, they reduce uterine hypercontractility. This provides significant relief for most patients.

Insulin is the primary pharmacological agent for managing gestational glycaemia when lifestyle modifications fail. It provides precise control of maternal blood sugar without interfering with fetal endocrine function. The molecular weight of insulin is too high to allow passive diffusion across the chorioamniotic membranes.

A. Insulin is cheaper: The cost of insulin and the required supplies for monitoring and injection is often significantly higher than oral medications. However, clinical choice is based on safety and efficacy rather than financial expenditure. Economics do not dictate the medical preference for insulin in pregnancy.

B. Insulin crosses the placenta easily: If insulin crossed the placenta, it would cause severe fetal hypoglycemia and hyperinsulinemia, leading to macrosomia and birth defects. The safety of insulin relies specifically on the fact that it remains within the maternal compartment. It does not enter fetal circulation.

C. Oral agents are ineffective: While some oral agents like metformin can lower blood sugar, they cross the placenta and their long-term effects on the fetus are still under investigation. Insulin remains the most potent and titratable option for achieving target glucose levels. It is the gold standard for clinical reliability.

D. Insulin does not cross the placenta: This characteristic ensures that the medication lowers maternal glucose without directly affecting the fetal pancreas. It prevents the risk of iatrogenic neonatal hypoglycemia while treating the mother's diabetes. This makes it the safest choice for the developing fetus.